{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:22:59Z","timestamp":1785813779092,"version":"3.56.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejmech.2020.112215","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T12:29:17Z","timestamp":1583756957000},"page":"112215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"special_numbering":"C","title":["Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review"],"prefix":"10.1016","volume":"193","author":[{"given":"Hua-Li","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zai-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindar","family":"Lekkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Rakesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112215_bib1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2020.112215_bib2","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1021\/jm301476b","article-title":"Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines","volume":"55","author":"Cabrera","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib3","series-title":"World Malaria Report","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112215_bib4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1186\/1475-2875-10-378","article-title":"A\u00a0new world malaria map: Plasmodium falciparum endemicity in 2010","volume":"10","author":"Gething","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112215_bib5","first-page":"1","volume":"vol. 80","year":"2012"},{"key":"10.1016\/j.ejmech.2020.112215_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","article-title":"Spread and evolution of Plasmodium falciparum drug resistance","volume":"58","author":"Mita","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2020.112215_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/138955709787316074","article-title":"Drug resistance in Plasmodium: natural products in the fight against malaria","volume":"9","author":"Turschner","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib8","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2020.112215_bib10","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"Ashley","year":"2018","journal-title":"Malaria, The Lancet"},{"key":"10.1016\/j.ejmech.2020.112215_bib11","first-page":"11","article-title":"Chalcone: a versatile molecule","volume":"1","author":"Patil","year":"2009","journal-title":"J.\u00a0Pharmaceut. Sci. Res."},{"key":"10.1016\/j.ejmech.2020.112215_bib12","first-page":"38","article-title":"Synthesis and antimicrobial screening of chalcones containing imidazo[1,2-a] pyridine nucleus","volume":"3","author":"Bhale","year":"2013","journal-title":"Res. J. Chem. Sci."},{"key":"10.1016\/j.ejmech.2020.112215_bib13","first-page":"82","article-title":"Synthesis and antimicrobial activity of 1-(2\u2019,4\u2019-dichlorophenyl)-3-(substituted aryl)-2-propene-1-ones","volume":"2","author":"Mohammad","year":"2012","journal-title":"Int. J. Life Sci. Pharm. Res."},{"key":"10.1016\/j.ejmech.2020.112215_bib14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/jhet.942","article-title":"Synthesis, characterization, and in\u00a0vitro antibacterial activities of macromolecules derived from bis-chalcone","volume":"49","author":"Asiri","year":"2012","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib15","doi-asserted-by":"crossref","first-page":"S2890","DOI":"10.1016\/j.arabjc.2013.11.018","article-title":"Green synthesis, characterization and biological evaluation of novel chalcones as antibacterial agents","volume":"10","author":"Khan","year":"2017","journal-title":"Ara. J. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib16","doi-asserted-by":"crossref","first-page":"103113","DOI":"10.1016\/j.bioorg.2019.103133","article-title":"Chalcone derivatives and their antibacterial activities: current development","volume":"91","author":"Xu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2018.06.009","article-title":"Multi-targetable chalcone analogs to treat deadly Alzheimer\u2019s disease: current view and upcoming advice","volume":"80","author":"Zhang","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2012.01383.x","article-title":"Antimalarial activity of newly synthesized chalcone derivatives in\u00a0Vitro","volume":"80","author":"Yadav","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112215_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2015.02.040","article-title":"An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents","volume":"93","author":"Insuasty","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bmcl.2006.11.051","article-title":"Synthesis and antimalarial evaluation of a series of piperazinyl flavones","volume":"17","author":"Auffret","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2013.02.037","article-title":"Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors","volume":"63","author":"Salum","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2013.01.027","article-title":"Synthesis, structure-activity relationship and mode of action of 3-substitutedphenyl-1-(2,2,8,8-tetramethyl-3,4,9,10-tetrahydro-2H, 8H-pyrano[2,3-f]chromen-6-yl)-propenones as novel anticancer agents in human leukaemia HL-60 cells","volume":"62","author":"Murthy","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib24","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.bmcl.2011.03.108","article-title":"A\u00a0novel, a broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1, Bioorg","volume":"21","author":"Yuan","year":"2011","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112215_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bioorg.2019.02.030","article-title":"The significance of N-methylpicolinamides in the development of anticancer therapeutics: synthesis and structure-activity relationship (SAR) studies","volume":"86","author":"Moku","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","article-title":"Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: a critical review","volume":"173","author":"Fang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2013.10.061","article-title":"Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents","volume":"74","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm7012166","article-title":"2-(3-aryl-3-oxopropen-1-yl)-9-tert-butyl-paullones: a new antileishmanial chemotype","volume":"51","author":"Reichwald","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ejmech.2012.05.041","article-title":"Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents","volume":"54","author":"Carvalho","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib30","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.bmc.2011.01.047","article-title":"Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors","volume":"19","author":"Sharma","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00044-010-9342-1","article-title":"Synthesis, antioxidant evaluation, and quantitative structure-activity relationship studies of chalcones","volume":"20","author":"Sivakumar","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112215_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bmc.2011.11.068","article-title":"Antioxidant properties of 4-quinolones and structurally related flavones","volume":"20","author":"Greeff","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejmech.2014.10.068","article-title":"Identification of quinoline-chalcone hybrids as potential antiulcer agents","volume":"89","author":"Sashidhara","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.foodchem.2010.01.022","article-title":"Glycosidase inhibitory phenolic compounds from the seed of Psoraleacorylifolia","volume":"121","author":"Oh","year":"2010","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bmc.2013.12.047","article-title":"Inhibition of tyrosinase activity by polyphenol compounds from Flemingiaphilippinensis roots","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/np100378d","article-title":"Estrogenic activity of chemical constituents from Tephrosia candida","volume":"74","author":"Hegazy","year":"2011","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2020.112215_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2015.00091","article-title":"How do antimalarial drugs reach their intracellular targets?","volume":"6","author":"Basore","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112215_bib38","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1590\/0001-3765201820170830","article-title":"Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives","volume":"90","author":"Pinheiro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejmech.2020.112215_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmac. Ther."},{"key":"10.1016\/j.ejmech.2020.112215_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/mr.43.4.453-495.1979","article-title":"Biochemistry of Plasmodium (malarial parasites)","volume":"43","author":"Sherman","year":"1979","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112215_bib41","first-page":"10","article-title":"Incorporation of radioactive precursors into Plasmodium berghei in\u00a0vitro","volume":"65","author":"Homewood","year":"1971","journal-title":"Trans. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112215_bib42","first-page":"447","article-title":"The ribosomes of the simian malaria Plasmodium knowlesi. II. A cell-free protein synthesising system","volume":"5311","author":"Sherman","year":"1976","journal-title":"Comp. Biochem. Physiol."},{"key":"10.1016\/j.ejmech.2020.112215_bib43","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1016\/0006-2952(89)90644-8","article-title":"In\u00a0vitro studies on the mode of action of quassinoids with activity against chloroquine-resistant Plasmodium faleiparum","volume":"38","author":"Kirby","year":"1989","journal-title":"Bioehem. Pharmac."},{"key":"10.1016\/j.ejmech.2020.112215_bib44","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1073\/pnas.88.11.4786","article-title":"Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum","volume":"88","author":"Surol1a","year":"1991","journal-title":"Proc. Natn. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112215_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.21.5.819","article-title":"Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex","volume":"21","author":"Fitch","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112215_bib46","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V62.6.1165.1165","article-title":"Intracellular ferriprotoporphyrin IX is a lytic agent","volume":"62","author":"Fitch","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2020.112215_bib47","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1016\/j.bmc.2010.10.009","article-title":"Design, synthesis and in\u00a0vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds","volume":"18","author":"Guantai","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib48","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bmc.2013.12.032","article-title":"Synthesis, in\u00a0vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides","volume":"22","author":"Smit","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib49","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/S0968-0896(03)00233-5","article-title":"Structure-activity relationships of antileishmanial and antimalarial chalcones","volume":"11","author":"Liu","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0223-5234(01)01245-4","article-title":"Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity","volume":"36","author":"Dominguez","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib51","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","article-title":"Licochalcone A, a new antimalarial agent, inhibits in\u00a0vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P.\u00a0yoelii infection","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112215_bib52","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1016\/j.bmcl.2012.07.028","article-title":"Synthesis and in\u00a0vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum","volume":"22","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib53","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ejmech.2017.04.063","article-title":"Cinnamoylated chloroquine analogues: a new structural class of antimalarial agents","volume":"135","author":"Gayam","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib54","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.bmc.2012.03.011","article-title":"Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores","volume":"20","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ejmech.2017.07.041","article-title":"4-Aminoquinoline-chalcone\/-N-acetylpyrazoline conjugates: synthesis and antiplasmodial evaluation","volume":"138","author":"Kumar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","article-title":"4-Aminoquinoline-ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib57","first-page":"851","article-title":"A\u00a0solid-phase synthesis of chalconesby Claisen-Schmidt condensations","volume":"11","author":"Cheng","year":"2000","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112215_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2015.03.045","article-title":"Synthesis and in\u00a0vitroantiplasmodial evaluation of 7-chloroquinoline-chalcone and 7-chloroquinoline-ferrocenylchalcone conjugates","volume":"95","author":"Raj","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib59","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in\u00a0vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib60","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00044-011-9694-1","article-title":"Design, synthesis and biological evaluation of some novel 3-cinnamoyl-4-hydroxy-2H-chromen-2-ones as antimalarial agents","volume":"21","author":"Patel","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112215_bib61","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1016\/j.bmcl.2010.05.069","article-title":"Synthesis of novel \u03b1-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors","volume":"20","author":"Wanare","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","article-title":"Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents","volume":"85","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib63","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ejmech.2007.09.014","article-title":"Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in\u00a0vitro","volume":"43","author":"Mishra","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2016.02.041","article-title":"Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities","volume":"113","author":"Kant","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2014.08.053","article-title":"1H-1,2,3-triazole tethered mono- and bis-ferrocenylchalcone-\u03b2-lactam conjugates: synthesis and antimalarial evaluation","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib66","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.bmc.2005.04.043","article-title":"New ether diglycosides from Mataybaguianensis with antiplasmodial activity","volume":"13","author":"Mesquita","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2016.05.069","article-title":"Polyvalent effect enhances diglycosidic antiplasmodial activity","volume":"121","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib68","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.ejmech.2009.02.008","article-title":"Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparumin\u00a0vitro","volume":"44","author":"Bhattacharya","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib69","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmcl.2010.02.017","article-title":"Comparison of the antiplasmodial and falcipain-2 inhibitory activity of \u03b2-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib70","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1073\/pnas.90.8.3583","volume":"90","author":"Ring","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112215_bib71","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/AAC.48.9.3241-3245.2004","article-title":"Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of plasmodium falciparum-infected erythrocytes, Antimicrob","volume":"48","author":"Go","year":"2004","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112215_bib72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2014.03.079","article-title":"Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum","volume":"79","author":"Sharma","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib73","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bmcl.2009.12.062","article-title":"Synthesis, antimalarial and antitubercular activity of acetylenic chalcones","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib74","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm00026a010","article-title":"In\u00a0vitro antimalarial activity of chalcones and their derivatives","volume":"38","author":"Li","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib75","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.bmcl.2005.07.012","article-title":"Conformationally restricted anti-plasmodial chalcones","volume":"15","author":"Larsen","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib76","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","article-title":"Licochalcone A, a new antimalarial agent, inhibits in\u00a0vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P.\u00a0yoelii infection","volume":"38","author":"Chen","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112215_bib77","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2012.01383.x","article-title":"Antimalarial activity of newly synthesized chalcone derivatives in\u00a0vitro","volume":"80","author":"Yadav","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112215_bib78","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1021\/jm0101747","article-title":"Antimalarial alkoxylated and hydroxylated chalcones: structure activity relationship analysis","volume":"44","author":"Liu","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib79","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1016\/j.ejmech.2010.08.049","article-title":"Reinvestigation of structure-activity relationship of methoxylated chalcones as antimalarials: synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural \u03b2-asarone","volume":"45","author":"Kumar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/jm201216y","article-title":"Stilbene-chalcone hybrids: design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis","volume":"55","author":"Sharma","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib81","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1039\/c2md20113e","article-title":"PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity","volume":"3","author":"Perez","year":"2012","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2020.112215_bib82","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejmech.2012.07.018","article-title":"One-pot efficient-diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agents","volume":"55","author":"Fatima","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/jm300588j","article-title":"Synthesis and insight into the structure-activity relationships of chalcones as antimalarial agents","volume":"56","author":"Tadigoppula","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib84","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.5012\/bkcs.2007.28.12.2495","article-title":"In\u00a0vitro antimalarial activity of flavonoids and chalcones","volume":"28","author":"Lim","year":"2007","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112215_bib85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00044-008-9137-9","article-title":"Potent antimalarial activity of newly synthesized substituted chalcone analogs in\u00a0vitro","volume":"18","author":"Awasthi","year":"2009","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112215_bib86","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejmech.2009.11.022","article-title":"Synthesis of new chalcone derivatives containing acridinyl moiety with potential antimalarial activity","volume":"45","author":"Tomar","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib87","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0960-894X(02)00430-4","article-title":"Antimalarial activity of ferrocenyl chalcones, Antimalarial activity of ferrocenyl chalcones","volume":"12","author":"Wu","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112215_bib88","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bioorg.2019.02.016","article-title":"Synthesis of novel chalcones through palladium-catalyzed C\u2013O cross-coupling reaction of bromo-chalcones with ethyl acetohydroxamate and their antiplasmodial evaluation against Plasmodium falcipuram in\u00a0Vitro","volume":"86","author":"Reeta","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112215_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.farmac.2005.01.005","article-title":"Synthesis and antimalarial activity of sulfonamide chalcone derivatives","volume":"60","author":"Dom\u00ednguez","year":"2005","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejmech.2020.112215_bib90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apjtb.2017.07.004","article-title":"Chalcone analogue as potent anti-malarial compounds against Plasmodium falciparum: synthesis, biological evaluation, and docking simulation study","volume":"7","author":"Syahri","year":"2017","journal-title":"Asian. Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejmech.2020.112215_bib91","doi-asserted-by":"crossref","first-page":"15276","DOI":"10.3390\/molecules181215276","article-title":"Anti-malarial activity of 4-metoxychalcones: docking studies as falcipain\/plasmepsin inhibitors, ADMET and lipophilic efficiency analysis to identify a putative oral lead candidate","volume":"18","author":"de Oliveira","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112215_bib92","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3390\/molecules19022166","article-title":"Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents","volume":"19","author":"Gil","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112215_bib93","doi-asserted-by":"crossref","unstructured":"Jyoti, R. Gaur, Y. Kumar, H.S. Cheema, D.S. Kapkoti, M.P. Darokar, Feroz Khan, R.S. Bhakuni, Synthesis, molecular modelling studies of indolyl chalcone derivatives and their antimalarial activity evaluation, Nat. Prod. Res. DOI: 10.1080\/14786419.2019.1696788.","DOI":"10.1080\/14786419.2019.1696788"},{"key":"10.1016\/j.ejmech.2020.112215_bib94","first-page":"1966","article-title":"Synthesis and antimalarial activities of chalcone derivatives","volume":"7","author":"David","year":"2014","journal-title":"Inter. J. Chem. Tech. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:07:28Z","timestamp":1759327648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420301823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":94,"alternative-id":["S0223523420301823"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112215","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112215"}}